Condition: Vulnerable Families · Sponsor: Nanyang Technological University
The current research aims to evaluate the effectiveness and feasibility of the Strong Families Through Art Therapy (SFAT) programme, which was developed to improve the parent-child relationship in vulnerable families. The main questions it aims to answer are: 1. Is the programme effective in enhancing quality of life and family resilience among parents? 2. Is the programme effective in enhancing quality of life among children? 3. Is the programme feasible and acceptable for large scale implementation in Singapore? Researchers will compare the status of family participants (caregivers and children) before and after they take the programme and compare family participants who take the programme with family participants who have not yet taken the programme to see if the programme is effective in benefiting the participants. Researchers will also invite family participants to discuss about the programme. Family participants will 1. Take the 10-week SFAT programme 2. Complete assessment survey for 3 times 3. Attend a focus group discussion (optional) To assess the programme feasibility, researchers will additional invite art therapist participants to evaluate the programme and invite community staff participants to discuss about the programme implementation. Art therapist participants will complete programme and session evaluation reports. Community staff participants will attend a focus group discussion.
This description comes directly from the study's public registry record.
Andy Hau Yan Ho, PhD, EdD · +65 6316 8943 · andyhyho@ntu.edu.sg
Stephanie Hilary Xinyi Ma, PhD · stephaniehilary.ma@ntu.edu.sg
Always discuss trial participation with your own doctor first.
| The Red Pencil Singapore | Singapore, Singapore | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06732297